|
|
||||||||
J Thorac Cardiovasc Surg 2006;131:547-557
© 2006 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease |
a Vanderbilt University, Nashville, Tenn
b Duke University Medical Center, Durham, NC
c Society of Thoracic Surgeons Adult Cardiac Surgery Database, Durham, NC
d Louisiana State University, New Orleans, La
e University of Florida, Jacksonville, Fla
Read at the Thirty-first Annual Meeting of The Western Thoracic Surgical Association, Victoria, BC, Canada, June 22-25, 2005.
Received for publication July 7, 2005; revisions received October 10, 2005; accepted for publication October 20, 2005. * Address for reprints: J. Scott Rankin, MD, 2400 Patterson St, Suite 103, Nashville, TN 37203 (Email: jsrankinmd{at}cs.com).
OBJECTIVE: In some respects, outcome reporting in valvular surgery has been hampered by focusing on specific populations, reluctance to publish high-risk subgroups, and possibly skewed or inadequate samples. The goal of this study was to evaluate risk factors for operative mortality comprehensively across the entire spectrum of cardiac valvular procedures over the past decade.
METHODS: All 409,904 valve procedures in the Society of Thoracic Surgeons database performed between 1994 and 2003 were assessed, and Society of Thoracic Surgeons preoperative and operative variables were related to operative mortality by using a multivariable logistic regression model. Data were greater than 95% complete, and the relative importance of relevant risk factors was determined by ranking odds ratios. The analysis had a high predictive power, with a C statistic of 0.735.
RESULTS: In the model, 19 variables independently influenced operative mortality (all P < .01). The most significant was nonelective (acute) presentation (odds ratios, 2.11), followed by advanced age (odds ratios, 1.88), reoperation (odds ratios, 1.61), endocarditis (odds ratios, 1.59), and coronary disease (odds ratios, 1.58). Generally, valve replacement was associated with higher mortality than repair (odds ratios, 1.52). Overall, female gender was very important (odds ratios, 1.37), and earlier year of operation increased risk (odds ratios, 1.34), implying improving outcomes over time. Although any single comorbidity, on average, was only moderately contributory (odds ratios, 1.19), specific comorbidities, such as renal failure, or multiple comorbidities in a given patient could be very significant. Aortic root reconstruction carried the highest risk (odds ratios, 2.78), followed by tricuspid valve surgery (odds ratios, 2.26), multiple valve procedures (odds ratios, 2.06), and then isolated mitral (odds ratios, 1.47), pulmonic (odds ratios, 1.29), and aortic (reference procedure) operations. Reduced ejection fraction and severity of valve lesion were relatively less important (odds ratios, 1.34 and 0.83, respectively).
CONCLUSIONS: These data illustrate the significance of acute presentation in determining operative risk, and earlier surgical intervention under elective conditions might be emphasized for all types of significant valve lesions. Because aortic root reconstruction doubles mortality compared with simple aortic valve procedures, root replacement should be reserved for specific root pathology. Finally, issues related to reoperation, endocarditis, valve repair, gender, and the various procedures deserve more detailed examination.
This article has been cited by other articles:
![]() |
F. Filsoufi, P. B. Rahmanian, J. G. Castillo, J. Chikwe, and D. H. Adams Logistic risk model predicting postoperative respiratory failure in patients undergoing valve surgery Eur. J. Cardiothorac. Surg., November 1, 2008; 34(5): 953 - 959. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. H. Thourani, R. Myung, P. Kilgo, K. Thompson, J. D. Puskas, O. M. Lattouf, W. A. Cooper, J. D. Vega, E. P. Chen, and R. A. Guyton Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective Ann. Thorac. Surg., November 1, 2008; 86(5): 1458 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Rahimtoola Valvular heart disease: a perspective on the asymptomatic patient with severe valvular aortic stenosis Eur. Heart J., July 2, 2008; 29(14): 1783 - 1790. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Verheugt, C. S.P.M. Uiterwaal, E. T. van der Velde, F. J. Meijboom, P. G. Pieper, H. W. Vliegen, A. P.J. van Dijk, B. J. Bouma, D. E. Grobbee, and B. J.M. Mulder Gender and Outcome in Adult Congenital Heart Disease Circulation, July 1, 2008; 118(1): 26 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Liao, D F Kong, Z Samad, P A Pappas, J G Jollis, S S Lin, A Wang, V G Fowler Jr, V H Chu, D J Sexton, et al. Echocardiographic risk stratification for early surgery with endocarditis: a cost-effectiveness analysis Heart, May 1, 2008; 94(5): e18 - e18. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. van Gameren, A. P. Kappetein, E. W. Steyerberg, A. C. Venema, E. A.J. Berenschot, E. L. Hannan, A. J.J.C. Bogers, and J. J.M. Takkenberg Do We Need Separate Risk Stratification Models for Hospital Mortality After Heart Valve Surgery? Ann. Thorac. Surg., March 1, 2008; 85(3): 921 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Silvay, J. G. Castillo, J. Chikwe, B. Flynn, and F. Filsoufi Cardiac Anesthesia and Surgery in Geriatric Patients Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2008; 12(1): 18 - 28. [Abstract] [PDF] |
||||
![]() |
F. Filsoufi, P. B. Rahmanian, J. G. Castillo, J. Chikwe, and D. H. Adams Predictors and Early and Late Outcomes of Respiratory Failure in Contemporary Cardiac Surgery Chest, March 1, 2008; 133(3): 713 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dhareshwar, T. M. Sundt III, J. A. Dearani, H. V. Schaff, D. J. Cook, and T. A. Orszulak Aortic root enlargement: What are the operative risks? J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 916 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Reece, R. R. Singh, B. M. Stiles, B. B. Peeler, J. A. Kern, C. G. Tribble, and I. L. Kron Replacement of the Proximal Aorta Adds No Further Risk to Aortic Valve Procedures Ann. Thorac. Surg., August 1, 2007; 84(2): 473 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. McKellar, D. J. Tester, M. Yagubyan, R. Majumdar, M. J. Ackerman, and T. M. Sundt III Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 290 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Rankin Amiodarone and cardiac surgery J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 271 - 271. [Full Text] [PDF] |
||||
![]() |
G. H.L. Tang, M. Maganti, T. E. David, C. M. Feindel, H. E. Scully, and M. A. Borger Effect of Prior Valve Type on Mortality in Reoperative Valve Surgery Ann. Thorac. Surg., March 1, 2007; 83(3): 938 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Florath, A. Albert, W. Hassanein, B. Arnrich, U. Rosendahl, I. C. Ennker, and J. Ennker Current determinants of 30-day and 3-month mortality in over 2000 aortic valve replacements: impact of routine laboratory parameters Eur. J. Cardiothorac. Surg., November 1, 2006; 30(5): 716 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Carroll The Evolving Treatment of Aortic Stenosis: Do New Procedures Provide New Treatment Options for the Highest-Risk Patients? Circulation, August 8, 2006; 114(6): 533 - 535. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |